US Supreme Court Human Genome Patents (Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 June 13, 2013 & now in Congress, the 'Patent Eligibility Restoration Act' of 2022/2023) to overturn patenting DNA decision
Tedros: "This week, WHO member states are hosting discussions on amendments to the International Health Regulations. Next week, countries will begin negotiations on a 'Zero Draft' of the new Pandemic Accord."